英文名称 |
中文名称 |
CAS |
NeMadipine B
|
非洛地平杂质B |
79925-38-5 |
IMpurity A of Falecalcitriol
|
氟骨化醇Trans杂质 |
303015-34-1 |
BAY-M 5579
|
1,4-二氢-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二羧酸单乙酯 |
74936-73-5 |
Paricalcitol
|
帕立骨化醇 |
131918-61-1 |
2β-trans-eldecalcitol
|
艾地骨化醇Trans杂质 |
861996-34-1 |
1,3-Cyclohexanediol, 4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1S)-5-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3S,5Z)-
|
骨化三醇20S杂质 |
134523-84-5 |
Calcitriol
|
骨化三醇 |
32222-06-3 |
(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methyl-6-triethylsilyloxyheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-one
|
骨化三醇CD环14-epi-杂质 |
1101133-55-4 |
Linagliptin Impurity C
|
利格列汀杂质C |
1791405-13-4 |
Calcitriol EP impurity A
|
骨化三醇Trans杂质 |
73837-24-8 |
(24R)-paricalcitol
|
帕立骨化醇24R杂质 |
132015-95-3 |
2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3
|
艾地骨化醇 |
104121-92-8 |
Linagliptin iMpurity G
|
利拉利汀杂质G |
668270-11-9 |
Linagliptin Impurity K
|
利格列汀杂质K |
1638744-06-5 |
Ethyl4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate
|
2-丙基-1H-咪唑-4,5-二羧酸二乙酯 |
144689-94-1 |
Felodipine 3,5-DiMethyl Ester
|
4-(2',3'-二氯苯基) -2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯 |
91189-59-2 |
Linagliptin Impurity F
|
利格列汀杂质F |
1673546-62-7 |
Dehydro Olmesartan
|
脱氢奥美沙坦 |
172875-98-8 |
Alfacalcidol
|
艾地骨化醇20S杂质 |
1217549-27-3 |
Olmesartan
|
奥美沙坦 |
144689-24-7 |
Ethyl4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate
|
4-(2-羟基丙-2-基)-2-丙基-1H-咪唑-5-羧酸乙酯 |
144689-93-0 |
OlmesartanEPImpurityB
|
奥美沙坦酯EP杂质B |
849206-43-5 |
Olmesartan Medoxomil Impurity U
|
奥美沙坦酯杂质U |
144689-23-6 |
Linagliptin N-Acetyl Impurity
|
利格列汀N-乙酰杂质 |
1803079-49-3 |
Linagliptin Impurity H
|
利格列汀杂质H |
1646355-34-1 |
Linagliptin Impurity JX
|
利格列汀杂质JX |
2137744-33-1 |
Trityl olmesartan
|
三苯甲基奥美沙坦酯 |
144690-92-6 |
FALECALCITRIOL
|
氟骨化醇 |
83805-11-2 |
Olmesartan MedoxomiI Impurity C
|
奥美沙坦酯C |
87956-26-2 |
1H-Indene-1-pentanol, octahydro-4-hydroxy-ε,7a-dimethyl-α,α-bis(trifluoromethyl)-, (εR,1R,3aR,4S,7aR)-
|
氟骨化醇CD环起始物料 |
2454249-03-5 |
ethyl 2-(4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate
|
2-(4-羟基苯基)-4-甲基噻唑-5-羧酸乙酯 |
161797-99-5 |
Olmesartan intermediate impurity IV
|
咪唑单乙酯杂质IV |
1092980-84-1 |
Methyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate
|
2-(3-氰基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸甲酯 |
923942-34-1 |
Febuxostat Impurity 8
|
非布索坦 杂质8 |
144060-62-8 |
ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE
|
2-(3-醛基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸乙酯 |
161798-03-4 |
Febuxostat Descyano Impurity
|
非布索坦杂质E |
1206550-99-3 |
4-Hydroxyisophthalonitrile
|
2,4-二氰基苯酚 |
34133-58-9 |
Ethyl2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate
|
2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸乙酯 |
160844-75-7 |
4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid
|
4-(2-羟异丙基)-2-丙基-1H-咪唑-5-甲酸 |
144690-04-0 |
Olmesartan Impurity 58
|
奥美沙坦杂质58 |
2190488-06-1 |
2-[3-(AMinocarbonyl)-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid
|
非布索坦相关物质 |
1239233-86-3 |
2-[3-Carboxy-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid
|
非布索坦杂质B |
1239233-87-4 |
FeBuxostat Impurity 18
|
非布索坦杂质18 |
1312815-35-2 |
ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate
|
非布索坦杂质39 |
2073891-59-3 |
OlMesartan interMediate iMpurity II
|
奥美沙坦酯杂质6 |
144690-07-3 |
Febuxostat Impurity 6
|
非布司他杂质6 |
1271738-74-9 |
2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid
|
非布索坦杂质T |
407582-48-3 |
4-(4-METHYL-1,3-THIAZOL-2-YL)PHENOL
|
2-(4-羟基苯基)-4-甲基噻唑 |
138330-01-5 |
Febuxostat Impurity 14
|
非布索坦杂质14 |
1335202-60-2 |
ethyl 2-(4-(sec-butoxy)-3-formylphenyl)-4-methylthiazole-5- carboxylate
|
非布索坦杂质47 |
2375033-31-9 |
4-(1-Methylethenyl)-2-propyl-1H-Imidazole-5-carboxylic acidethylester
|
乙基-4-(丙-1-烯-2-基)-2-丙基 |
157356-73-5 |
ethyl 2-(4-butoxy-3-formylphenyl)-4-methylthiazole-5- carboxylate
|
非布索坦杂质45 |
2230270-03-6 |
5-(5-(ethoxycarbonyl)-4-methylthiazol-2-yl)-2-isobutoxybenzoic acid
|
非布索坦杂质55 |
2095166-41-7 |
5-Thiazolecarboxylic acid, 2-[3-(ethoxycarbonyl)-4-(2-methylpropoxy)phenyl]-4-methyl-
|
非布索坦杂质49 |
2476465-11-7 |
2-(4-HYDROXY-PHENYL)-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID
|
非布索坦杂质1 |
886501-78-6 |
4-(1-Hydroxy-1-methylpropyl)-2-propyl-1H-Imidazole-5-carboxylic acidethylester
|
咪唑单乙酯杂质I |
172875-53-5 |
Febuxostat Impurity 7
|
非布司他杂质7 |
1350352-70-3 |
Febuxostat Impurity 130
|
Febuxostat Impurity 130 |
1643131-93-4 |
2-(2-Hydroxyphenyl)-4-methyl-5-thiazolecarboxylic acid ethyl ester
|
非布索坦中间体杂质 |
118485-48-6 |
Olmesartan Impurity 9
|
奥美沙坦杂质9 |
849206-42-4 |
ethyl 2-(3-carbamoyl-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate
|
非布索坦杂质54 |
1346238-15-0 |
Febuxostat Impurity 32 HCl
|
非布司他杂质32 HCL |
1267681-15-1 |
Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol)
|
左沙丁胺醇相关物质E |
754926-25-5 |
Dehydro Nifedipine N-Oxide
|
去氢硝苯地平-N-氧化物 |
88434-69-9 |
5-(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydrop yridine-3-carboxylic acid
|
硝苯地平杂质07 |
74936-71-3 |
Nifedipine
|
硝苯地平杂质 |
17438-14-1 |
vildagliptin Impurity F
|
维格列汀杂质F |
1789703-36-1 |
methyl (Z)-2-(2-nitrosobenzylidene)-3-oxobutanoate
|
硝苯地平EP杂质C |
39562-27-1 |
Vildagliptin IMpurity 2 (Mixture of DiastereoMers)
|
维格列汀杂质B |
1036959-23-5 |
Norfloxacin Impurity 6
|
诺氟沙星杂质6 |
126192-88-9 |
diethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5- dicarboxylate
|
硝苯地平杂质08 |
21829-26-5 |
Nifedipine Impurity 21
|
硝苯地平杂质21 |
80742-13-8 |
Salbutamol EP Impurity B
|
沙丁胺醇EP杂质B |
96948-64-0 |
Nifedipine Impurity E
|
硝苯地平杂质E |
114709-68-1 |
DehydroNifedipine
|
4 - (2硝基苯基)-2,6 -二甲基吡啶-3,5二羧酸二甲酯 |
67035-22-7 |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-(2-Cyanoethyl) 5-Methyl Ester
|
乐卡地平杂质 |
75130-24-4 |
2,6-Dichloro-4,8-dipiperidinopyrimidino[5,4-d]pyrimidine
|
2,6-二氯-4,8-二哌啶子基嘧啶并[5,4-D]嘧啶 |
7139-02-8 |
Vildagliptin carboxy acid metabolite
|
维格列汀杂质 |
565453-40-9 |
Dipyridamole EP Impurity C
|
双嘧达莫EP杂质C |
54093-92-4 |
Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol)
|
左沙丁胺醇相关物质C |
18910-70-8 |
vildagliptin Impurity R
|
维格列汀杂质R |
1803168-09-3 |
m-Nifedipine
|
4-(间硝基苯基)-2,6-二甲基-1,4-二氢-3,5-吡啶二羧酸二甲酯 |
21881-77-6 |
Dehydronitrosonifedipine
|
脱氢亚硝苯地平 |
50428-14-3 |
4-CHLOROPHTHALIC ACID MONOSODIUM SALT
|
4-氯邻苯二甲酸单钠盐 |
56047-23-5 |
Dipyridamole EP Impurity D
|
双嘧达莫EP杂质D |
1176886-12-6 |
3-ethyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine- 3,5-dicarboxylate
|
硝苯地平杂质06 |
53055-15-5 |
Nifedipine Impurity 7
|
硝苯地平杂质7 |
80742-11-6 |
Nimodipine Related Compound B
|
尼莫地平相关物质B |
70172-96-2 |
Nonivamide
|
辣椒碱 |
2444-46-4 |
Dipyridamole EP Impurity F
|
双嘧达莫EP杂质F |
60286-30-8 |
Nimodipine EP Impurity B
|
尼莫地平EP杂质B |
21881-78-7 |
dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarb oxylate
|
贝尼地平杂质B |
21829-09-4 |
Dipyridamole EP Impurity B
|
双嘧达莫EP杂质B |
16908-47-7 |
Dipyridamole EP Impurity A
|
双嘧达莫EP杂质A |
16982-40-4 |
N-DesMethyl DiphenhydraMine Hydrochloride
|
2-(二苯基甲氧基)-N-甲基乙胺盐酸盐 |
53499-40-4 |
Nitrendipine EP Impurity C
|
尼群地平EP杂质C |
21829-28-7 |
Vildagliptin (2R)-Isomer
|
维格列汀杂质1 |
1036959-27-9 |
vildagliptin Impurity C
|
维格列汀杂质C |
565453-39-6 |
vildagliptin Impurity E
|
维格列汀杂质E |
1789703-37-2 |
Cerium silicide
|
硅化铈 |
12014-85-6 |